Innovation in the Times of the COVID-19 – THE GRANT PROCESS
We are focusing on the development of new ideas in the time of Covid-19. Right now, corporate innovation and licensing has slowed, as R&D budgets are being cut. New biotech developments have slowed as lab activity has been curtailed. The Angel and VC markets, already risk adverse, have become more conservative.
In these times, startups will need funding but, just as importantly, independent validation of their ideas via the grant processes. By leveraging these grant based resources and applications, startups can find validation of their ideas and processes as well as received undiluted funding to advance their technology. From there, the startup will be in a stronger position to negotiate exits with these partners. The SBIR process involved extensive reviews of your idea from science experts, business experts, and project development experts, all of which will provide opportunities to fine tune your idea to commercialization.
We will discuss the Phase I grant, where the technical merit of the project is discussed. In Phase II, we will discuss taking your idea to the marketplaces. Then you can talk to the Angels, VCs and corporate licensing folks from a position of strength.
For the startup, this means planning the entire life cycle of your idea and figuring out where the exit ramps are located.
After the session, we will have an open discussion of the business / technical / funding challenges of your companies. Bring your questions and problems, the answers may be of interest to other folks as well. Led by guest speaker Earle Hager, Managing Partner / The Neutrino Donut, LLC Mr. Hager has worked extensively on technology assessment, business development, and grant process for several hundred startups. He has even does those Net Present Value spreadsheets required for financial planning on grants. He also knows almost everyone you may need to connect with in the corporate market. He comes to Los Angeles via Philadelphia and Austin.